Invention Grant
- Patent Title: Quinolinone compound and use thereof
-
Application No.: US15502499Application Date: 2015-09-01
-
Publication No.: US10065928B2Publication Date: 2018-09-04
- Inventor: Yinglin Zuo , Xiaojun Wang , Yingjun Zhang , Liang Wen , Shoutao Wu , Xiaofeng Yuan
- Applicant: Sunshine Lake Pharma Co., Ltd.
- Applicant Address: CN Dongguan, Guangdong
- Assignee: SUNSHINE LAKE PHARMA CO., LTD.
- Current Assignee: SUNSHINE LAKE PHARMA CO., LTD.
- Current Assignee Address: CN Dongguan, Guangdong
- Agency: Kam Wah Law
- Priority: CN201410442574 20140902
- International Application: PCT/CN2015/088799 WO 20150901
- International Announcement: WO2016/034108 WO 20160310
- Main IPC: C07D215/56
- IPC: C07D215/56 ; C07D215/54 ; C07D401/04 ; C07D401/12 ; C07D413/12 ; A61P9/10 ; A61P7/06
Abstract:
Provided herein are a quinolinone compound, pharmaceutical composition thereof, and use of the compound or the pharmaceutical composition in drug preparation, the drug being used to prevent, manage, treat or relieve diseases related to HIF and/or EPO of a patient, including anemia, vascular disease, myocardial ischemia, dysmetabolism, or for wound healing.
Public/Granted literature
- US20170247332A1 QUINOLINONE COMPOUND AND USE THEREOF Public/Granted day:2017-08-31
Information query
